Research resource: Estrogen-Driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia

Molecular Endocrinology

Volumn 24, Issue 11, 2010, Pages 2207-2217

  Tam, Neville N C ^a   Szeto, Carol Y Y ^a,b   Freudenberg, Johannes M ^a   Fullenkamp, Amy N ^a   Medvedovic, Mario ^a   Ho, Shuk Mei ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; ESTROGEN; FULVESTRANT; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MAPPING; HYPOPHYSIS; IMMUNE RESPONSE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RAT;

ANIMALS; BROMOCRIPTINE; CALGRANULIN B; CELL PROLIFERATION; CHEMOKINE CXCL13; EPITHELIAL CELLS; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; INTERLEUKIN-1BETA; MALE; PROLACTIN; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RATS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTOSTERONE;

RATTUS; RODENTIA;

EID: 78049341414     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0179     Document Type: Article

References (55)

1. Bosland MC 2000 The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 39-66
2. Prins GS, Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73:233-244
3. McPherson SJ, Ellem SJ, Risbridger GP 2008 Estrogen-regulated development and differentiation of the prostate. Differentiation 76:660-670
4. Rohrmann S, Nelson WG, Rifai N, Brown TR, Dobs A, Kanarek N, Yager JD, Platz EA 2007 Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab 92:2519-2525 (Pubitemid 47037352)
5. Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E, Burzon D, Bostwick D, Steiner M 2006 Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial. J Urol 176:965-970
6. Krieg M, Nass R, Tunn S 1993 Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 77:375-381 (Pubitemid 23230043)
7. Bartke A, Doherty PC, Steger RW, Morgan WW, Amador AG, Herbert DC, Siler-Khodr TM, Smith MS, Klemcke HG, Hymer WC 1984 Effects of estrogen-induced hyperprolactinemia on endocrine and sexual functions in adult male rats. Neuroendocrinology 39:126-135 (Pubitemid 14094324)
8. Costello LC, Franklin RB 1994 Effect of prolactin on the prostate. Prostate 24:162-166
9. Tangbanluekal L, Robinette CL 1993 Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats. Endocrinology 132:2407-2416 (Pubitemid 23156888)
10. Gilleran JP, Putz O, DeJong M, DeJong S, Birch L, Pu Y, Huang L, Prins GS 2003 The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Endocrinology 144:2046-2054 (Pubitemid 36543345)
11. Lissoni P, Bignami A, Frontini L, Manganini V, Dapretto E, Gardani GS, Viganò P, Strada G 2005 Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. Int J Biol Markers 20:123-125 (Pubitemid 41052458)
12. Stattin P, Rinaldi S, Stenman UH, Riboli E, Hallmans G, Bergh A, Kaaks R 2001 Plasma prolactin and prostate cancer risk: a prospective study. Int J Cancer 92:463-465 (Pubitemid 32249727)
13. Leav I, Merk FB, Lee KF, Loda M, Mandoki M, McNeal JE, Ho SM 1999 Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions. Am J Pathol 154:863-870 (Pubitemid 29122605)
14. Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT 2008 Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clin Cancer Res 14:1317-1324 (Pubitemid 351413910)
15. Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT 2007 Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology 148:3089-3101 (Pubitemid 46996970)
16. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW, Damassa D 1988 Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 80:1045-1053
17. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP 2008 Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 22:1512-1520 (Pubitemid 351656791)
18. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR 2000 Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res 60:6008-6017
19. Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM 1997 Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 18:1505-1510 (Pubitemid 28134772)
20. Thompson CJ, Tam NN, Joyce JM, Leav I, Ho SM 2002 Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780. Endocrinology 143:2093-2105 (Pubitemid 34521557)
21. Wennbo H, Kindblom J, Isaksson OG, Törnell J 1997 Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138:4410-4415 (Pubitemid 27408488)
22. Kindblom J, Dillner K, Sahlin L, Robertson F, Ormandy C, Törnell J, Wennbo H 2003 Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. Endocrinology 144:2269-2278 (Pubitemid 36629877)
23. Robertson FG, Harris J, Naylor MJ, Oakes SR, Kindblom J, Dillner K, Wennbo H, Törnell J, Kelly PA, Green J, Ormandy CJ 2003 Prostate development and carcinogenesis in prolactin receptor knockout mice. Endocrinology 144:3196-3205 (Pubitemid 36819922)
24. Germano G, Allavena P, Mantovani A 2008 Cytokines as a key component of cancer-related inflammation. Cytokine 43:374-379
25. Markowski MC, Bowen C, Gelmann EP 2008 Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res 68:6896-6901
26. Savli H, Szendröi A, Romics I, Nagy B 2008 Gene network and canonical pathway analysis in prostate cancer: a microarray study. Exp Mol Med 40:176-185 (Pubitemid 351738723)
27. Zabaleta J, Su LJ, Lin HY, Sierra RA, Hall MC, Sartor AO, Clark PE, Hu JJ, Ochoa AC 2009 Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis 30:1358-1362
28. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D 2005 Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 11:5146-5152 (Pubitemid 41003699)
29. Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, Brorsson AC, Tartaglia GG, Vogl T, Kayed R, Wingsle G, Olsson J, Dobson CM, Bergh A, Elgh F, Morozova-Roche LA 2009 Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS One 4:e5562
30. Sfanos KS, Wilson BA, De Marzo AM, Isaacs WB 2009 Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci USA 106:3443-3448
31. Boyanovsky BB, Webb NR 2009 Biology of secretory phospholipase A2. Cardiovasc Drugs Ther 23:61-72
32. Grkovich A, Dennis EA 2009 Phosphatidic acid phosphohydrolase in the regulation of inflammatory signaling. Adv Enzyme Regul 49:114-120
33. Menschikowski M, Hagelgans A, Gussakovsky E, Kostka H, Paley EL, Siegert G 2008 Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms. Neoplasia 10:279-286 (Pubitemid 351328586)
34. Tam NN, Leav I, Ho SM 2007 Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 171:1334-1341 (Pubitemid 47582906)
35. Bernoulli J, Yatkin E, Talvitie EM, Santti R, Streng T 2007 Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation. Prostate 67:888-899 (Pubitemid 46828943)
36. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185
37. Leav I, Galluzzi CM, Ziar J, Stork PJ, Ho SM, Loda M 1996 Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. Lab Invest 75:361-370 (Pubitemid 26314521)
38. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D 2006 S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312:184-197 (Pubitemid 41721180)
39. Tsai CY, Lee TS, Kou YR, Wu YL 2009 Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation. J Cell Biochem 108:489-498
40. Misra UK, Deedwania R, Pizzo SV 2006 Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem 281:13694-13707 (Pubitemid 43855285)
41. Vacherot F, Caruelle D, Chopin D, Gil-Diez S, Barritault D, Caruelle JP, Courty J 1999 Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate 38:126-136 (Pubitemid 29052951)
42. Hatziapostolou M, Delbe J, Katsoris P, Polytarchou C, Courty J, Papadimitriou E 2005 Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Prostate 65:151-158 (Pubitemid 41362282)
43. Li SC, Chen GF, Chan PS, Choi HL, Ho SM, Chan FL 2001 Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. Prostate 49:58-71
44. Wong YC, Tam NN 2002 Dedifferentiation of stromal smooth muscle as a factor in prostate carcinogenesis. Differentiation 70:633-645
45. Dillner K, Kindblom J, Flores-Morales A, Shao R, Törnell J, Norstedt G, Wennbo H 2003 Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate. Endocrinology 144:4955-4966 (Pubitemid 37378410)
46. Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM, Harkonen PL 1997 Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest 99:618-627 (Pubitemid 27097662)
47. Ellem SJ, Wang H, Poutanen M, Risbridger GP 2009 Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 175:1187-1199
48. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD 2004 Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64:2270-2305
49. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS 2006 Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-5632
50. Bolstad BM, Irizarry RA, Astrand M, Speed TP 2003 A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193 (Pubitemid 36181903)
51. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F 2005 Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175 (Pubitemid 41806403)
52. Huang da W, Sherman BT, Lempicki RA 2009 Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
53. Winer J, Jung CK, Shackel I, Williams PM 1999 Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49 (Pubitemid 29230718)
54. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
55. Chang SM, Chung LW 1989 Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology 125:2719-2727